Substance Modalities
We observed a high prevalence of marijuana vaporization and smoking, and
a surprisingly high utilization of inhalational methods for CBD. CBD is
often less frequently asked about among CF healthcare teams, and many CF
care providers feel unprepared to answer questions regarding
CBD9. Given the potential for worsening lung disease
and respiratory symptoms10, it is vital to routinely
discuss both marijuana and CBD usage, counsel, and discuss modalities.
Inhaling any substance can exacerbate airway inflammation and hasten
lung damage, especially in those already afflicted with underlying lung
disease9. Furthermore, alternative forms of marijuana
and CBD, such as edibles and topical solutions, present challenges due
to their higher cost11, limited
accessibility12, and potential interactions with CFTR
modulator drugs13, thereby potentially complicating
their usage as an alternative to CF management strategies.